|Bid||4.9800 x 0|
|Ask||4.9900 x 0|
|Day's Range||4.9700 - 5.0000|
|52 Week Range||2.3500 - 5.0800|
|Beta (5Y Monthly)||3.11|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Apr. 29, 1998|
|1y Target Est||N/A|
CRH Medical Corporation (TSX: CRH) (NYSE American: CRHM) ("CRH" or the "Company") announced today that it has filed with the U.S. Securities and Exchange Commission (the "SEC") a Current Report on Form 8-K containing certain disclosures that are intended to amend and supplement the Company's proxy statement and management information circular, dated March 19, 2021 (the "Circular"), relating to the special meeting of CRH securityholders that will be held in connection with the proposed acquisition of CRH by WELL Health Technologies Corp. (the "Arrangement"), which Circular was previously mailed to securityholders. The Current Report and supplemental disclosures are available on the SEC's website at http://www.sec.gov, on SEDAR at www.sedar.com and on the Company's website at http://investors.crhsystem.com.
CRH Medical Corporation ("CRH", or the "Company") (TSX: CRH) (NYSE MKT: CRHM) announces that it has completed an accretive transaction whereby the Company has acquired the remaining 25% interest in Lake Lanier Anesthesia Associates ("LLAA") a gastroenterology anesthesia practice located in Georgia. CRH initially acquired 75% of LLAA in June of 2020.This transaction will increase adjusted operating EBITDA attributable to shareholders, as CRH now owns 100% of LLAA. This transaction was financed through a combination of CRH's credit facility and cash on hand.
CRH Medical Corporation ("CRH", or the "Company") (TSX: CRH) (NYSE MKT: CRHM) announces that it completed an accretive transaction whereby the Company has acquired a 51% interest in Middle Arkansas Sedation Associates, LLC ("MASA"), a gastroenterology anesthesia practice located in Little Rock, Arkansas.